Teladoc Health Inc (TDOC) Shares Bought by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. lifted its holdings in shares of Teladoc Health Inc (NYSE:TDOC) by 47.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 47,400 shares of the health services provider’s stock after buying an additional 15,300 shares during the quarter. Mirae Asset Global Investments Co. Ltd. owned approximately 0.07% of Teladoc Health worth $4,093,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in the company. Principal Financial Group Inc. boosted its position in shares of Teladoc Health by 3.4% during the first quarter. Principal Financial Group Inc. now owns 118,266 shares of the health services provider’s stock worth $4,767,000 after purchasing an additional 3,839 shares in the last quarter. Aperio Group LLC bought a new position in shares of Teladoc Health during the second quarter worth $201,000. Raymond James Financial Services Advisors Inc. boosted its position in shares of Teladoc Health by 140.9% during the second quarter. Raymond James Financial Services Advisors Inc. now owns 23,736 shares of the health services provider’s stock worth $1,378,000 after purchasing an additional 13,883 shares in the last quarter. TD Asset Management Inc. boosted its position in shares of Teladoc Health by 28.9% during the second quarter. TD Asset Management Inc. now owns 97,800 shares of the health services provider’s stock worth $5,677,000 after purchasing an additional 21,900 shares in the last quarter. Finally, Commonwealth Equity Services LLC boosted its position in shares of Teladoc Health by 13.0% during the second quarter. Commonwealth Equity Services LLC now owns 24,464 shares of the health services provider’s stock worth $1,420,000 after purchasing an additional 2,809 shares in the last quarter.

Shares of NYSE:TDOC opened at $53.41 on Friday. The company has a debt-to-equity ratio of 0.40, a quick ratio of 8.99 and a current ratio of 8.99. Teladoc Health Inc has a one year low of $30.88 and a one year high of $89.05.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Thursday, November 1st. The health services provider reported ($0.34) EPS for the quarter, topping the consensus estimate of ($0.36) by $0.02. Teladoc Health had a negative net margin of 31.32% and a negative return on equity of 14.05%. The firm had revenue of $111.00 million for the quarter, compared to analysts’ expectations of $109.94 million. During the same period in the previous year, the firm posted ($0.55) EPS. The company’s revenue for the quarter was up 61.6% on a year-over-year basis. Sell-side analysts forecast that Teladoc Health Inc will post -1.47 earnings per share for the current fiscal year.

In other Teladoc Health news, insider Adam C. Vandervoort sold 5,550 shares of the business’s stock in a transaction dated Monday, September 10th. The shares were sold at an average price of $77.67, for a total transaction of $431,068.50. Following the sale, the insider now directly owns 2,934 shares of the company’s stock, valued at approximately $227,883.78. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Jason N. Gorevic sold 35,000 shares of the business’s stock in a transaction dated Monday, November 19th. The stock was sold at an average price of $54.80, for a total transaction of $1,918,000.00. Following the sale, the chief executive officer now directly owns 541,184 shares in the company, valued at $29,656,883.20. The disclosure for this sale can be found here. Insiders have sold a total of 255,929 shares of company stock worth $17,683,623 over the last three months. Insiders own 3.95% of the company’s stock.

Several equities research analysts recently commented on TDOC shares. Jefferies Financial Group set a $90.00 price objective on shares of Teladoc Health and gave the company a “buy” rating in a research report on Friday, September 28th. Citigroup reaffirmed a “buy” rating and issued a $95.00 price objective on shares of Teladoc Health in a research report on Friday, September 28th. Canaccord Genuity boosted their price objective on shares of Teladoc Health from $86.00 to $94.00 and gave the company a “buy” rating in a research report on Friday, September 28th. SunTrust Banks boosted their price objective on shares of Teladoc Health to $100.00 and gave the company a “buy” rating in a research report on Monday, September 24th. Finally, Craig Hallum boosted their price objective on shares of Teladoc Health from $70.00 to $80.00 and gave the company a “buy” rating in a research report on Monday, October 15th. Four analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company. Teladoc Health has a consensus rating of “Buy” and an average target price of $85.06.

TRADEMARK VIOLATION WARNING: “Teladoc Health Inc (TDOC) Shares Bought by Mirae Asset Global Investments Co. Ltd.” was reported by American Banking News and is the property of of American Banking News. If you are reading this report on another publication, it was stolen and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this report can be viewed at https://www.americanbankingnews.com/2018/12/08/teladoc-health-inc-tdoc-shares-bought-by-mirae-asset-global-investments-co-ltd.html.

Teladoc Health Company Profile

Teladoc Health, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

See Also: Catch-Up Contributions

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply